Activity Downloads

To Participate

To participate in this continuing education activity:

1. Review the activity description and objectives.
2. View the activity.
3. Complete the online post-test and activity evaluation.

Activity Description

This educational activity will describe the impact of hyperglycemia in the critical care setting, as well as research on the development of clinical targets for optimal glycemic control. Appropriate management of hyperglycemia in critically ill patients, including current authoritative recommendations shall be discussed. Individualized dosing protocols for insulin infusion management through electronic or paper-based mechanisms will be considered.

Learning Objectives

Upon completion of this activity, pharmacists and nurses will be able to:

• Outline the clinical evidence surrounding tight glycemic control in the ICU
• Discuss the economic impact of tight glycemic control in the ICU
• Describe the variable intra-patient physiology of glycemic control
• Describe the appropriate use of technology in managing glycemic control
• Identify the potential for medication errors related to glycemic control

Faculty

Michael T. Johnson, PharmD
MSICU-Clinical Pharmacist
University of Illinois Medical Center
Clinical Assistant Professor
University of Illinois
College of Pharmacy
Chicago, Illinois

Michael Magee, RPh
Pharmacy Clinical Coordinator
Wyoming Medical Center
Casper, Wyoming

Stanley A. Nasraway, MD, FCCM
Director, Surgical Intensive Care Units
Tufts Medical Center
Professor of Surgery, Medicine & Anesthesia
Tufts University School of Medicine
Boston, Massachusetts

Disclosure

It is the policy of ProCE to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) discussed in an educational presentation. Michael Johnson has served as a consultant/speaker for Hospira. Michael Magee has nothing to disclose. Stanley Nasraway has nothing to disclose. A portion of grant funds received by ProCE from Hospira will be used to compensate the faculty for this activity.

Please note: The opinions expressed in this activity should not be construed as those of the CE provider or Hospira, Inc. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs for unlabeled indications. Use of drugs outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.

CE Accreditation

Release Date: 01-16-2012
Expiration Date: 12-05-2014

Pharmacists:

ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 221-000-12-004-H01-P has been assigned to this knowledge-based, home-study activity (initial release date 01-16-12). This CE activity is approved for 2.0 contact hours (0.20 CEUs) in states that recognize ACPE providers. The activity is provided at no cost to participants. Statements of credit will be issued online upon completion of the activity evaluation and the post-test with a score of 70% or higher. No partial credit will be given.

Nurses:

Nursing credit is provided for this home-study activity through collaboration between ProCE, Inc. and Wild Iris Medical Education, Inc., a provider of continuing education accredited by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides 2.0 contact hours of nurse CE credit.

Funding

This activity is supported by an educational grant from Hospira, Inc.

The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

Activity Announcement